10% Off
Supotaria50 mg
Incepta Pharmaceuticals Ltd.
৳108.00
Add to cart
Generic medicine
Glycopyrrolate: Brands, Price & Uses in Bangladesh
Glycopyrrolate is a synthetic anticholinergic (antimuscarinic) agent used for several distinct, evidence-graded indications: Established / FDA-approved uses Perioperative antisialagogue: Reduces…
About Glycopyrrolate
Indications of Glycopyrrolate
Glycopyrrolate is a synthetic anticholinergic (antimuscarinic) agent used for several distinct, evidence-graded indications:
Established / FDA-approved uses
- Perioperative antisialagogue: Reduces salivary, tracheobronchial, and pharyngeal secretions before general anesthesia and blocks vagally-mediated cardiac reflexes during induction and intubation.
- Reversal of neuromuscular blockade: Given together with an anticholinesterase (e.g., neostigmine) to counteract muscarinic side effects (bradycardia, excess secretions) when reversing non-depolarizing neuromuscular block.
- Chronic sialorrhea (severe drooling): Oral solution formulations are approved to reduce chronic, severe drooling associated with neurologic conditions such as cerebral palsy in pediatric patients.
- Maintenance treatment of COPD: Inhaled long-acting muscarinic antagonist (LAMA) formulations of Glycopyrrolate are approved for long-term, once/twice-daily maintenance bronchodilator therapy in chronic obstructive pulmonary disease. Not indicated for acute bronchospasm.
- Primary axillary hyperhidrosis: Topical formulations are approved for excessive underarm sweating.
Adjunct / combination-therapy use
- Peptic ulcer disease: Used as an adjunct to other measures (acid suppression, lifestyle) to reduce gastric acid and motility; not first-line monotherapy by modern standards.
Glycopyrrolate inhalation products for COPD are not a substitute for rescue bronchodilators and are not approved for asthma.
Dosage & Administration of Glycopyrrolate
Dosing of Glycopyrrolate is individualized by indication, route, patient age, and clinical response. The following is a general summary; the treating physician's prescription takes precedence.
| Indication | Typical adult dose | Pediatric dose |
|---|---|---|
| Reduction of secretions before anesthesia | 0.004 mg/kg (4 mcg/kg) intramuscularly 30–60 minutes before induction, or 0.1 mg intravenously at induction, repeated as needed | Weight-based dosing under anesthesiologist supervision; safety in neonates not fully established |
| Reversal of neuromuscular blockade | 0.2 mg Glycopyrrolate for each 1 mg of neostigmine (or approx. 5 mcg/kg intravenously), given simultaneously | Used under specialist supervision, weight-based |
| Adjunct treatment of peptic ulcer disease | 1–2 mg orally two to three times daily, individualized to the lowest effective dose (maximum around 8 mg/day) | Not established |
| Chronic severe drooling (sialorrhea) | Not an adult-labeled indication | Oral solution, starting around 0.02 mg/kg/dose three times daily, titrated gradually to effect/tolerability (only in patients 3 years and older, under specialist supervision) |
| COPD maintenance (inhaled) | One inhalation of the approved inhaled formulation once or twice daily, as directed by the device labeling; not for acute relief | Not established for pediatric use |
| Primary axillary hyperhidrosis (topical) | Apply to each underarm once daily as directed | Approved from around 9 years of age for the topical form |
Renal/hepatic impairment: Because Glycopyrrolate is largely renally eliminated, use with caution and consider dose reduction/extended dosing intervals in significant renal impairment; no universally established formal dose-adjustment schedule exists, so individualize under physician guidance.
Do not change the dose, frequency, or duration of Glycopyrrolate without consulting the prescribing physician.
Side Effects of Glycopyrrolate
Side effects of Glycopyrrolate are predominantly anticholinergic and dose-related:
Very common
- Dry mouth (often the most common, dose-limiting effect)
- Decreased sweating
Common
- Blurred vision, mydriasis (pupil dilation), photophobia
- Constipation
- Urinary hesitancy or retention
- Tachycardia, palpitations, facial flushing
- Nausea
Less common
- Dizziness, headache, drowsiness (less prominent than with atropine)
- Allergic/hypersensitivity reactions
Report persistent or severe side effects to the prescribing physician.
Contraindications of Glycopyrrolate
Glycopyrrolate is contraindicated in patients with:
- Known hypersensitivity to Glycopyrrolate or any component of the formulation.
- Narrow-angle glaucoma.
- Obstructive uropathy (e.g., bladder-neck obstruction due to prostatic hypertrophy).
- Obstructive disease of the gastrointestinal tract (e.g., pyloroduodenal stenosis).
- Paralytic ileus.
- Severe ulcerative colitis (risk of precipitating toxic megacolon), and in patients with unstable cardiovascular status during acute hemorrhage.
- Myasthenia gravis.
Frequently Asked Questions about Glycopyrrolate
What is Glycopyrrolate used for?
Glycopyrrolate is an anticholinergic (antimuscarinic) medicine used to reduce salivary, gastric, and airway secretions before surgery, to help reverse the effects of certain muscle-relaxant drugs, as an adjunct in peptic ulcer disease, to control chronic severe drooling in some children with neurologic conditions, and, in inhaled form, as a long-term maintenance treatment for COPD.
Can I take Glycopyrrolate if I am pregnant or breastfeeding?
Glycopyrrolate should be used in pregnancy only if clearly needed, because the potential benefit must be weighed against the potential risk to the fetus, and there is limited human safety data. During breastfeeding, Glycopyrrolate may reduce milk production and its effect on a nursing infant is not well established, so it should only be used under medical supervision. Always consult your physician before using Glycopyrrolate in pregnancy or while breastfeeding.
Who should not use Glycopyrrolate?
Glycopyrrolate must not be used by people with known hypersensitivity to it, narrow-angle glaucoma, obstructive uropathy (such as bladder-neck obstruction from prostate enlargement), obstructive disease of the gastrointestinal tract (e.g., pyloroduodenal stenosis), paralytic ileus, severe ulcerative colitis, or myasthenia gravis. Tell your doctor about your full medical history before starting Glycopyrrolate.
What are the common side effects of Glycopyrrolate?
The most common side effect of Glycopyrrolate is dry mouth, along with decreased sweating. Other common effects include blurred vision, constipation, difficulty urinating, and a faster heartbeat. These effects are usually dose-related; tell your doctor if they are severe or persistent.
What should I do if I take too much Glycopyrrolate (overdose)?
An overdose of Glycopyrrolate can cause a hot, flushed, dry skin, high fever, dilated pupils, a fast heartbeat, urinary retention, and confusion. This is a medical emergency — seek immediate medical attention or contact emergency services/poison control right away rather than trying to treat it at home.
Can Glycopyrrolate be used in children?
Yes, in specific approved forms. Glycopyrrolate oral solution is approved for chronic, severe drooling in children 3 years and older with certain neurologic conditions, using a carefully titrated weight-based dose. Other uses of Glycopyrrolate in children (such as peptic ulcer disease or COPD) are not well established, so pediatric use should always be directed by a physician.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.